Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD)/ribavirin-Reference-Cited by-同舟云学术

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD)/ribavirin

Published:2005-09 Issue:3 Volume:43 Page:425-433
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Ferenci Peter,Fried Michael W.,Shiffman Mitchell L.,Smith Coleman I.,Marinos George,Gonçales Fernando L.,Häussinger Dieter,Diago Moises,Carosi Giampero,Dhumeaux Daniel,Craxì Antonio,Chaneac Monique,Reddy K. Rajender

Publisher

Elsevier BV

Subject

Hepatology

Reference16 articles.

1. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

2. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

3. Peginterferon-alfa2a and ribavirin combination therapy in chronic hepatitis C. A randomized study of treatment duration and ribavirin dose;Hadziyannis;Ann Intern Med,2004

4. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002-June 10-12, 2002. Hepatology, 2002; 36: S3-20.

5. Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C;Davis;Hepatology,2003

Cited by 449 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-10 and IL-28B gene variants as predictors of sustained response to peginterferon and ribavirin therapy in chronic HCV infection;Cytokine;2022-03

2. Genomic divergence of Hepatitis C virus towards common prescribed interferon regimens on sustained virologic response (SVR) ‎;Journal Of Advanced Pharmacy Education And Research;2022

3. Association between interleukin 28B polymorphism and sustained virological response to sofosbuvir plus daclatasvir in chronic hepatitis C genotype 4 Egyptian patients;Journal of Clinical Pharmacy and Therapeutics;2021-03-25

4. Iminosugars: A host-targeted approach to combat Flaviviridae infections;Antiviral Research;2020-12

5. Modelling the impact of different testing strategies for HCV infection in Switzerland;Journal of Virus Eradication;2019-10